Biosig Technologies Stock Performance
| BSGM Stock | USD 1.41 0.13 8.44% |
On a scale of 0 to 100, Biosig Technologies holds a performance score of 3. The firm shows a Beta (market volatility) of 1.1, which signifies a somewhat significant risk relative to the market. Biosig Technologies returns are very sensitive to returns on the market. As the market goes up or down, Biosig Technologies is expected to follow. Please check Biosig Technologies' sortino ratio, skewness, price action indicator, as well as the relationship between the potential upside and rate of daily change , to make a quick decision on whether Biosig Technologies' price patterns will revert.
Risk-Adjusted Performance
3 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Biosig Technologies are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating technical and fundamental indicators, Biosig Technologies displayed solid returns over the last few months and may actually be approaching a breakup point. ...more
Last Split Factor 1:10 | Dividend Date 2018-09-11 | Last Split Date 2024-02-02 |
1 | BioSig announces layoffs as part of cost-cutting effort | 01/30/2024 |
2 | Should You Buy BioSig Technologies Inc Stock on Friday - InvestorsObserver | 02/02/2024 |
3 | BioSig Technologies, Inc. Revenue Breakdown NASDAQBSGM TradingView - TradingView | 02/15/2024 |
4 | BioSig Technologies Inc Faces Wave of Executive Resignations - TipRanks.com - TipRanks | 02/21/2024 |
5 | Acquisition by Frederick Hrkac of 500000 shares of Biosig Technologies subject to Rule 16b-3 | 03/01/2024 |
6 | Acquisition by Kenneth Londoner of 1000 shares of Biosig Technologies at 1.56 subject to Rule 16b-3 | 03/18/2024 |
7 | Acquisition by Kenneth Londoner of 11850 shares of Biosig Technologies at 1.1425 subject to Rule 16b-3 | 03/28/2024 |
8 | BioSig Engages Consulting Firm for Business Model Strategies | 04/04/2024 |
9 | Acquisition by Kenneth Londoner of 11700 shares of Biosig Technologies at 3.18 subject to Rule 16b-3 | 04/05/2024 |
10 | 12 Health Care Stocks Moving In Mondays Intraday Session - BioSig Technologies , Alterity T - Benzinga | 04/15/2024 |
| Begin Period Cash Flow | 357 K |
Biosig |
Biosig Technologies Relative Risk vs. Return Landscape
If you would invest 227.00 in Biosig Technologies on January 24, 2024 and sell it today you would lose (86.00) from holding Biosig Technologies or give up 37.89% of portfolio value over 90 days. Biosig Technologies is currently generating 0.8315% in daily expected returns and assumes 19.9546% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Biosig, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Biosig Technologies Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Biosig Technologies' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Biosig Technologies, and traders can use it to determine the average amount a Biosig Technologies' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0417
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | BSGM | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 19.95 actual daily | 96 96% of assets are less volatile |
Expected Return
| 0.83 actual daily | 16 84% of assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 3 97% of assets perform better |
Based on monthly moving average Biosig Technologies is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Biosig Technologies by adding it to a well-diversified portfolio.
Biosig Technologies Fundamentals Growth
Biosig Stock prices reflect investors' perceptions of the future prospects and financial health of Biosig Technologies, and Biosig Technologies fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Biosig Stock performance.
| Return On Equity | -59.77 | ||||
| Return On Asset | -6.03 | ||||
| Operating Margin | (513.92) % | ||||
| Current Valuation | 16.18 M | ||||
| Shares Outstanding | 11.2 M | ||||
| Price To Earning | (3.73) X | ||||
| Price To Book | 36.58 X | ||||
| Price To Sales | 90.04 X | ||||
| Revenue | 18 K | ||||
| Gross Profit | 242 K | ||||
| EBITDA | (28.15 M) | ||||
| Net Income | (28.69 M) | ||||
| Cash And Equivalents | 887 K | ||||
| Cash Per Share | 0.02 X | ||||
| Total Debt | 452 K | ||||
| Debt To Equity | 0.45 % | ||||
| Current Ratio | 1.22 X | ||||
| Book Value Per Share | (0.33) X | ||||
| Cash Flow From Operations | (17.31 M) | ||||
| Earnings Per Share | (3.95) X | ||||
| Market Capitalization | 15.79 M | ||||
| Total Asset | 1.8 M | ||||
| Retained Earnings | (245.01 M) | ||||
| Working Capital | (4.05 M) | ||||
| Current Asset | 984.54 K | ||||
| Current Liabilities | 2.47 M | ||||
About Biosig Technologies Performance
To evaluate Biosig Technologies Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Biosig Technologies generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Biosig Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Biosig Technologies market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Biosig's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | (104.14) | (98.93) | |
| Return On Tangible Assets | (19.25) | (18.28) | |
| Return On Capital Employed | 10.24 | 10.75 | |
| Return On Assets | (16.15) | (15.34) | |
| Return On Equity | 9.97 | 10.47 |
Things to note about Biosig Technologies performance evaluation
Checking the ongoing alerts about Biosig Technologies for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Biosig Technologies help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Biosig Technologies is way too risky over 90 days horizon | |
| Biosig Technologies may become a speculative penny stock | |
| Biosig Technologies appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 18 K. Net Loss for the year was (28.69 M) with profit before overhead, payroll, taxes, and interest of 242 K. | |
| Biosig Technologies currently holds about 887 K in cash with (17.31 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02. | |
| Roughly 19.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: 12 Health Care Stocks Moving In Mondays Intraday Session - BioSig Technologies , Alterity T - Benzinga |
- Analyzing Biosig Technologies' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Biosig Technologies' stock is overvalued or undervalued compared to its peers.
- Examining Biosig Technologies' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Biosig Technologies' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Biosig Technologies' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Biosig Technologies' stock. These opinions can provide insight into Biosig Technologies' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biosig Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. To learn how to invest in Biosig Stock, please use our How to Invest in Biosig Technologies guide.Note that the Biosig Technologies information on this page should be used as a complementary analysis to other Biosig Technologies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Complementary Tools for Biosig Stock analysis
When running Biosig Technologies' price analysis, check to measure Biosig Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biosig Technologies is operating at the current time. Most of Biosig Technologies' value examination focuses on studying past and present price action to predict the probability of Biosig Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biosig Technologies' price. Additionally, you may evaluate how the addition of Biosig Technologies to your portfolios can decrease your overall portfolio volatility.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |
Is Biosig Technologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biosig Technologies. If investors know Biosig will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biosig Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.95) | Revenue Per Share 0.002 | Quarterly Revenue Growth (0.91) | Return On Assets (6.03) | Return On Equity (59.77) |
The market value of Biosig Technologies is measured differently than its book value, which is the value of Biosig that is recorded on the company's balance sheet. Investors also form their own opinion of Biosig Technologies' value that differs from its market value or its book value, called intrinsic value, which is Biosig Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biosig Technologies' market value can be influenced by many factors that don't directly affect Biosig Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biosig Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Biosig Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biosig Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.